BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36940199)

  • 1. Multidrug-Resistant Trichomoniasis: Successful Treatment With 3 Months of Twice-Daily Intravaginal Boric Acid.
    Seyedroudbari S; McCloskey K; Muzny CA; Graziani A; Momplaisir F
    Sex Transm Dis; 2023 Jul; 50(7):452-454. PubMed ID: 36940199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichomoniasis.
    Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
    Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid.
    Muzny C; Barnes A; Mena L
    Sex Health; 2012 Sep; 9(4):389-91. PubMed ID: 22877600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichomoniasis: the "neglected" sexually transmitted disease.
    Meites E
    Infect Dis Clin North Am; 2013 Dec; 27(4):755-64. PubMed ID: 24275268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Trichomoniasis in the Setting of 5-Nitroimidazole Hypersensitivity.
    Van Gerwen OT; Camino AF; Bourla LN; Legendre D; Muzny CA
    Sex Transm Dis; 2021 Aug; 48(8):e111-e115. PubMed ID: 33137011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial effect of boric acid on Trichomonas vaginalis.
    Brittingham A; Wilson WA
    Sex Transm Dis; 2014 Dec; 41(12):718-22. PubMed ID: 25581807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis?
    Thorley N; Ross J
    Sex Transm Infect; 2018 Dec; 94(8):574-577. PubMed ID: 29223972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichomoniasis refractory to 5-nitroimidazole therapy in Trinidad.
    Edwards RJ; Parboo M; Edwards J; Boyce G
    Trop Doct; 2023 Jan; 53(1):143-145. PubMed ID: 36214266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification.
    Aggarwal A; Shier RM
    J Obstet Gynaecol Can; 2008 Jan; 30(1):55-58. PubMed ID: 18198069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroimidazole Resistance in Trichomonas vaginalis Infection: A Teachable Moment.
    Salas A; Hamill MM; Tuddenham S
    JAMA Intern Med; 2019 Feb; 179(2):247-248. PubMed ID: 30575848
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapeutic options for the treatment of human trichomoniasis.
    Küng E; Fürnkranz U; Walochnik J
    Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Persistent 5-Nitroimidazole-Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid.
    McNeil CJ; Williamson JC; Muzny CA
    Sex Transm Dis; 2023 Apr; 50(4):243-246. PubMed ID: 36730040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observations on trichomonas vaginalis vaginitis associated with venereal disease; its treatment].
    ROUHUNKOSKI S
    Duodecim; 1948; 64(1):40-6. PubMed ID: 18883164
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report.
    Tayal S
    Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.